Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

How Early Data Drives Better Cell Line Performance
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory expectations. Yet one factor often determines long-term success more than any other: the strength of the data generated in the earliest phases of cell line development. read more
AI in Pharmacovigilance: Key Takeaways from Boehringer Ingelheim’s Recent Rollout
In conversation with Pharmaceutical Outsourcing, Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, reflect on some of the lessons learned from Boehringer’s deployment of AI to date in targeted use cases, starting with adverse event case intake and processing. read more
Hasty Decisions, Runaway Projects
Despite the best intentions of ISO and EMA, the pharma industry is still largely failing to exploit its data in a strategic, joined-up way - and this could now restrict companies’ ability to capitalize on AI. read more
Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
Tuesday, June 30, 2026
AustinPx announced its agreement with Thermo Fisher Scientific’s Patheon pharma services for the installation of AustinPx’s KinetiSol™ Technology ... read more
Lonza to Add ADC Payload-Linker Capacity at Visp
Tuesday, June 30, 2026
Lonza plans to expand payload-linker manufacturing capacity at its Visp, Switzerland, site to meet rising demand in the fast-growing antibody-drug ... read more
WuXi Biologics Receives Brazil ANVISA GMP Certification to Enable Global Commercial Manufacturing of Innovative Cancer Immunotherapy
Tuesday, June 30, 2026
WuXi Biologics announced that two of its manufacturing facilities in Wuxi — Drug Substance Facility 2 (MFG2) and Drug Product Facility 1 (DP1) — ... read more
OrganaBio Expands Rapid PBMC Processing to San Diego at Excellos Labs
Monday, June 29, 2026
OrganaBio announced the opening of a new PBMC processing and cryopreservation laboratory at Excellos Labs in San Diego, further strengthening its ... read more
Adragos Pharma Kawagoe Signs Agreement with Towa Pharmaceutical for Strategic Collaboration to Support Supply of Off-Patent Medicines
Monday, June 29, 2026
Adragos Pharma Kawagoe K.K. announced the signing of an agreement with Towa Pharmaceutical to establish a strategic collaboration aimed at ensuring ... read more